GOSSELIES, Belgium, December 06, 2023 Regulatory News: TheraVet (ISIN: BE0974387194 – ticker: ALVET), a pioneering company in the management of osteoarticular diseases in pets, updates on the Osteosarcoma Program achievements in 2023.
TheraVet Announces 300% Increase in Participating Centers in the Osteosarcoma Program Since Its Initiation 6 Months Ago finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Fast-growing interest in Osteosarcoma Program since official launch end- March 2023 with a 33% increase in participating Centers16 participating Centers in 7 countriesSuccessful participation to the congress of the European Society of Veterinary OncologyGOSSELIES, Belgium (BUSINESS WIRE) Regulatory News:TheraVet (.